chevron_leftBack
F
As of 6 June 2026, First Tracks Biotherapeutics, Inc. has a market cap of $821.46M USD, ranking #11904 globally and #2287 in the United States.
It ranks #1087 in the Healthcare sector, and #203 in the Biotechnology industry.
Key Stats
Market Cap
$821.46MUSD
Enterprise Value
$511.43MUSD
EBITDA (TTM)
-$178.45MUSD
Net Income (TTM)
-$166.09MUSD
PB Ratio
2.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Daniel Faga
open_in_new
Employees
104
Founded
2025
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 18% | 25% | -22% | -17% | -17% | -17% |
News
Loading...
TRAX Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
TRAX
ISIN: US3371851029
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
23.64 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was incorporated in 2025 and is headquartered in San Diego, California. First Tracks Biotherapeutics, Inc. operates as a subsidiary of AnaptysBio, Inc.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
22K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
19K%
|
19.0
|
|
NASDAQ: NTRA
|
$27.6B
3K%
|
-
|
|
NYSE: IQV
|
$26.3B
3K%
|
20.0
|
|
NASDAQ: UTHR
|
$25.03B
3K%
|
20.4
|
|
NASDAQ: MRNA
|
$18.13B
2K%
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
EBR: ARGX
|
$48.08B
6K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.48B
5K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$43.01B
5K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.72B
5K%
33.71B CHF
|
37.2
|
|
KRX: 068270
|
$27.89B
3K%
42.76T KRW
|
43.8
|
|
NASDAQ: BNTX
|
$25.69B
3K%
|
-
|
chevron_leftBack